Chemoinformaics analysis of 5-Hydroxy-4-(Hydroxymethyl)-Pyran-2-One
| Molecular Weight | 142.11 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 7 |
| Exact Molecular Weight | 142.027 | nRing | 1 |
| Solubility: LogS | 0.465 | nHRing | 1 |
| Solubility: LogP | -0.731 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 17.2288 |
| nHD | 2 | BPOL | 8.62324 |
| QED | 0.571 |
| Synth | 2.699 |
| Natural Product Likeliness | 1.608 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.872 |
| HIA | 0.011 |
| CACO-2 | -4.695 |
| MDCK | 0.000171814 |
| BBB | 0.09 |
| PPB | 0.491258 |
| VDSS | 0.678 |
| FU | 0.683309 |
| CYP1A2-inh | 0.241 |
| CYP1A2-sub | 0.238 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.342 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.444 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.125 |
| CL | 10.999 |
| T12 | 0.923 |
| hERG | 0.074 |
| Ames | 0.02 |
| ROA | 0.189 |
| SkinSen | 0.599 |
| Carcinogencity | 0.802 |
| EI | 0.977 |
| Respiratory | 0.206 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.903796 |